PERSISTENT

INFECTION

CLINICAL VALIDATION

REMDESIVIR

POST-TREATMENT

REBOUND

CLINICAL VALIDATION

PHASE II

CLINICAL TRIAL

CLINICAL VALIDATION

ACE2 EXPRESSION

AS A PREDICTIVE BIOMARKER

CLINICAL VALIDATION

PERSISTENT

INFECTION

CLINICAL VALIDATION

AI-DISCOVERED

COMPLETE AETIOLOGY &

TREATMENT

RATIONALE

COVID-19 DISEASE MODEL

& PREDICTION

AI-DISCOVERED

COMPLETE AETIOLOGY &

TREATMENT

RATIONALE

COVID-19 DISEASE MODEL

& PREDICTION

WHO ESSENTIAL MEDICINE

TREATMENTS PROPOSAL

DRUG DISCOVERY

& PREDICTION

REMDESIVIR

CHILOROQUINE

PI3K INHIBITORS

DRUG DISCOVERY

& PREDICTION

AI-DISCOVERED

PI3K-P110𝛂

INHIBITORS

TREATMENTS

DRUG DISCOVERY

& PREDICTION

AI-DISCOVERED

PI3K 

INHIBITORS

TREATMENTS

DRUG DISCOVERY

& PREDICTION

logo front page.png

© 2015-2020 by Demiurge Technologies AG. All Rights Reserved.